| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46 |
| filingDate |
1999-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e16676a77164ad4ada4fe3e2fe845c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71486eb3d3e154d17571843bd3d2be05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c113ca8d79b9941cd19fb9addc68b48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_742ae302b917d2bedd33b19b3cd86c2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63b926b97e55b8ca4890a518f6fc8930 |
| publicationDate |
2003-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BG-64074-B1 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITIONS CONTAINING EFFECUSTETIC ACID-BASED DUST |
| abstract |
The pharmaceutical composition is in the form of effervescent tablets containing the active substance and an effervescent mixture that includes an acid component and sodium glycine carbonate as an alkaline ingredient. Preferred acidic constituents are fumaric and maleic acid and their salts. The tablets are obtained by direct compression under normal thermo-hygrometric conditions and with standard tableting equipment. |
| priorityDate |
1997-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |